11/25
08:43 am
ima
ImageneBio (NASDAQ:IMA) is now covered by analysts at Wedbush. They set an "underperform" rating and a $2.00 price target on the stock.
Medium
Report
ImageneBio (NASDAQ:IMA) is now covered by analysts at Wedbush. They set an "underperform" rating and a $2.00 price target on the stock.
11/15
01:42 am
ima
Medium
Report
11/12
07:35 am
ima
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team [Yahoo! Finance]
Low
Report
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team [Yahoo! Finance]
11/12
07:15 am
ima
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team
Low
Report
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team
11/6
08:30 am
ima
ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences
Medium
Report
ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences
10/25
07:12 am
ima
ImageneBio (NASDAQ:IMA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Low
Report
ImageneBio (NASDAQ:IMA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
10/24
08:06 am
ima
ImageneBio (NASDAQ:IMA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $30.00 price target on the stock.
Medium
Report
ImageneBio (NASDAQ:IMA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $30.00 price target on the stock.
10/22
12:18 pm
ima
ImageneBio (NASDAQ:IMA) is now covered by analysts at
Weiss Ratings. They set a "sell (e-)" rating on the stock.
Low
Report
ImageneBio (NASDAQ:IMA) is now covered by analysts at
Weiss Ratings. They set a "sell (e-)" rating on the stock.
10/1
05:47 am
ima
ImageneBio (NASDAQ:IMA) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
ImageneBio (NASDAQ:IMA) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
9/27
12:38 am
ima
Low
Report